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TNF-a induced apoptosis in a feline fibroblastic cell line (CRFK) infected with FIV but not in its uninfected control. In this
study, to understand the molecular basis of the different susceptibilities to TNF-a between FIV-infected and uninfected cells,
we examined the expression of TNF receptors and the activation of the caspase and NF-kB pathways. Expression levels of
TNFR I and TNFR II mRNAs were similar between uninfected and FIV-infected CRFK cells. To understand the role of caspases
in TNF-a-induced apoptosis, we examined the effect of three different classes of caspase inhibitors, Z-VAD-FMK, Ac-YVAD-
CMK, and Z-DEVD-FMK, on the TNF-a-induced apoptosis in FIV-infected cells. Pretreatment with each of these caspase
inhibitors protected FIV-infected CRFK cells from TNF-a-induced cell death. Moreover, one of the caspase substrates,
poly(ADP-ribose) polymerase, was shown to be cleaved after TNF-a treatment in FIV-infected CRFK cells but not in uninfected
CRFK cells. Electrophoretic mobility shift assay using an NF-kB motif oligonucleotide and promoter assay using an NF-kB
luciferase reporter construct indicated that TNF-a treatment had induced activation of NF-kB in both FIV-infected and
uninfected CRFK cells. The present study indicates that TNF-a-induced apoptosis in FIV-infected CRFK cells is mediated by
the activation of the caspase cascade, but not by either upregulation of TNF receptor or inhibition of NF-kB. © 2001 Academic
Press
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Feline immunodeficiency virus (FIV) was first isolated
in 1987 by Pedersen et al. (1987) and belongs to the
genus lentivirus, like human immunodeficiency virus
(HIV) and simian immunodeficiency virus (SIV). Cats in-
fected with FIV show variable clinical signs according to
the progression of the disease stage. At the AIDS stage,
infected cats show debilitating symptoms such as pro-
found anemia (Shelton et al., 1991), opportunistic infec-
tions (Ishida et al., 1992), and tumors (Beatty et al.,
1998a,b). The pathogenesis of FIV infection is not fully
understood; however, it has been shown that the im-
mune system is progressively impaired according to the
advancement of the disease stage (Torten et al., 1991).
FIV infection in cats results in nonspecific polyclonal
activation of B cells which is mediated by increased
production of IL-6 (Flynn et al., 1994; Lawrence et al.,
1995; Ohashi et al., 1992). PBMC from symptomatic FIV-
infected cats showed depressed IL-2 production in re-
sponse to mitogens (Lawrence et al., 1992), accompa-
nied by significant increases in IL-1, IL-6, and TNF-a
production (Lawrence et al., 1995).
TNF-a is known as a proinflammatory cytokine pro-
uced in response to infection and inflammation. In FIVd
a
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446nfection, many studies on the production of TNF-a have
been reported. Serum TNF-a levels were shown to be
ncreased in cats experimentally infected with FIV (Leh-
ann et al., 1992; Lawrence et al., 1992) as well as in
those naturally infected with the virus (Lawrence et al.,
1995). Kraus et al. reported increased TNF-a mRNA level
ntimately linked to the expression of FIV p26 in lymph
odes of FIV-infected cats (Kraus et al., 1996). In in vitro
culture, infection with one strain of FIV, FIV-5122, induced
a significant increase in the mRNA level of TNF-a (Lin-
enberger and Deng, 1999). Recently, it was reported that
a positive correlation was found between viral RNA load
and TNF-a mRNA expression in the central nervous
system of cats acutely infected with FIV (Poli et al., 1999).
These studies indicate that TNF-a is closely associated
ith the pathogenesis of FIV infection.
Two cell surface receptors, TNF receptor type I (TNFR
) and TNF receptor type II (TNFR II), have been identified
s cellular receptors for TNF-a. It has been shown that
oth receptors are expressed in a wide variety of cell
ypes, but TNFR I and TNFR II were shown to transduce
ignals in different manners (Wallach et al., 1999). TNFR
transduces death signals as well as survival signals,
hereas TNFR II transduces only survival signals. TNFR
has an 80-amino-acid domain in the intracellular region,
alled the death domain, which is required for the trans-
uction of the death signal. In general, induction of
poptosis by TNF-a is mediated by a family of interleukin
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447TNF-a-INDUCED DEATH IN FIV-INFECTED CELLS1b-converting enzyme (ICE)-related proteases, the
aspases. On reception of a death signal, a cascade of
roteolytic cleavages results in the activation of the pre-
xisting inactive caspases, which finally destroy the cell.
aspases have been classified into two groups, up-
tream caspases, which act as initiators of the death
ignal from the cell surface receptor, and downstream
aspases, which act as executioners of apoptosis. The
ownstream caspases cleave and inactivate proteins
rucial for the maintenance of cytoskeleton, DNA repair,
ignal transduction, and cell cycle control and finally
nduce cell death. In addition to the death signal, TNFR I
an also transduce a survival signal or an antiapoptotic
ignal, through the activation of NF-kB (Beg and Balti-
more, 1996). The NF-kB family plays a key role in the
egulation of cell growth and survival (May and Ghosh,
998). In quiescent cells, NF-kB is inactive because of its
ocalization in the cytoplasm, which is regulated by in-
ibitory proteins, the Ik-B family. Following exposure of
he cells to TNF-a, activation of NF-kB is initiated. Dis-
ociation of Ik-B from NF-kB leads to the generation of
the nuclear localization signal in NF-kB, which allows
F-kB to translocate to the nucleus, where it serves as a
transcriptional regulator. Unlike TNFR I, the signaling
through TNFR II is unclear. Signaling through TNFR II
requires its intracellular domain, which has no death
domain. TNF-a usually induces cell death when active
ene expression is inhibited, suggesting that the death
ignal is mediated by molecules present in a quiescent
hase.
FIV infection in cats is associated with various immu-
ological abnormalities and induces lymphopenia in the
IDS stage (Sparkes et al., 1993). Lymphoid depletion is
bserved at the terminal stage in both HIV infection in
umans and FIV infection in cats (Kohmoto et al., 1998;
Matsumura et al., 1994). In HIV infection, it has been
suggested that the decrease of CD41 T cells is mediated
by the apoptotic mechanism (Jaworowski and Crowe,
1999). We and others reported that lymphocytes from
FIV-infected cats are prone to die in short-term culture
(Bishop et al., 1993; Guiot et al., 1993; Holznagel et al.,
1998; Johnson et al., 1996; Momoi et al., 1996). In feline
T-lymphoblastoid cell lines, FIV infection rapidly induces
obvious apoptosis (Ohno et al., 1994). Moreover, we
demonstrated that a feline fibroblastic cell line (CRFK)
chronically infected with FIV underwent apoptosis after
treatment with TNF-a (Ohno et al., 1993).
For cats, there are several reports describing the
apoptotic mechanism and genes associated with
apoptosis (Haagmans et al., 1996; Hofmann-Lehmann et
al., 1998; Holznagel et al., 1996; Ikeda et al., 1997, 1998;
ojko et al., 1992, 1996). We have carried out molecular
loning of the feline Fas antigen, Fas ligand (Mizuno et
l., 1998), and TNFR I (GenBank/EMBL/DDBJ Accession
o. AB051103). Sequence of feline TNFR II gene is also
vailable from the nucleotide sequence data base (Gen-
b
sank/EMBL/DDBJ Accession No. U51429). In this study,
o identify the mechanism of apoptosis in FIV infection,
e examined the expression of TNFRs and activation of
he caspase and NF-kB pathways in CRFK cells infected
with FIV that underwent apoptosis by treatment with
TNF-a.
RESULTS
TNFRs were expressed in both CRFK and CRFK/FIV
cells
To examine the difference of susceptibility to TNF-a in
the induction of apoptosis between CRFK and CRFK/FIV
cells, we first examined the expression of TNFR mRNAs
by reverse transcriptase (RT)-PCR. Figure 1 shows the
results of gel electrophoresis after RT-PCR of 15, 20, 25,
and 30 cycles for TNFR I and TNFR II mRNAs. Amplified
fragments of feline TNFR I and TNFR II were 215 and 244
bp, respectively, the sizes expected from the feline TNFR
I and TNFR II cDNA sequences. The bands amplified
from TNFR I mRNA became visible after 25 cycles of PCR
and were distinct after the 30 cycles in both CRFK and
CRFK/FIV cells. The bands amplified from TNFR II mRNA
were also similar between CRFK and CRFK/FIV cells,
although the bands in CRFK/FIV cells were slightly less
intense than those in CRFK cells after 25 and 30 cycles.
RT-PCR analysis carried out in this study indicated that
the expression levels of TNFR I and TNFR II mRNAs were
similar between uninfected CRFK cells and CRFK/FIV
cells.
CRFK cells were sensitive to TNF-a-induced
apoptosis in the presence of Actinomycin D (ActD)
and Cycloheximide (CHX)
The TNFRs on CRFK/FIV cells were considered to be
functional, because we previously showed that CRFK/FIV
cells underwent apoptosis after treatment with TNF-a
(Ohno et al., 1993). Many studies on apoptosis induced
FIG. 1. Expression of TNFR I and TNFR II mRNAs in uninfected CRFK
and CRFK/FIV cells. TNFR I, TNFR II, and b-actin mRNAs were analyzed
by RT-PCR by using primers specific to these molecules of the cat. The
numbers above the lanes indicate the cycle numbers of PCR.y TNF-a have shown that inhibition of RNA or protein
ynthesis sensitizes cells to apoptosis (Hill et al., 1995;
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448 MIZUNO ET AL.Kull and Cuatrecasas, 1981; Nio et al., 1990; Utaisincha-
roen et al., 1999). To examine whether TNFRs on unin-
fected CRFK cells are functional, we examined whether
FIG. 2. Induction of cell death in uninfected CRFK cells by treatment
with TNF-a. Uninfected CRFK cells were treated with different concen-
rations of TNF-a 2 h after pretreatment with 0.1 mg of ActD per milliliter
open circles) or 0.1 mg of CHX per milliliter (open squares) or without
ither (closed circles). After treatment with TNF-a for 12 h, the percent-
ages of cytotoxicity were determined by measurement of LDH activity
released from the cells. Results are expressed as means 6 standard
deviation (SD) of triplicate assays.
FIG. 3. Inhibition of TNF-a-induced cell death in CRFK/FIV cells by
ndicated concentrations of caspase inhibitors Z-VAD-FMK (A), Z-DEV
resence of TNF-a (5 ng/ml) (open circles) or in its absence (open squares). A
etermined by measurement of LDH activity released from the cells. Resultstreatments with ActD and CHX influence TNF-a-induced
cell death in CRFK cells. As shown in Fig. 2, in the
absence of ActD and CHX, cell death of up to 30% of the
cells was observed in uninfected CRFK cells at a high
concentration of TNF-a (10 ng/ml). Pretreatment with
ctD and CHX resulted in a marked increase in cytotox-
city even at low concentrations of TNF-a (0.1 and 1
ng/ml). This result indicated that TNFR on uninfected
CRFK cells was also functional, as shown in CRFK/FIV
cells.
Caspase inhibitor blocked TNF-a-induced apoptosis in
CRFK/FIV cells
To examine whether TNF-a-induced cell death in
RFK/FIV cells is inhibited by caspase inhibitors, three
inds of caspase inhibitors, Z-VAD-FMK, Z-DEVD-FMK,
nd Ac-YVAD-FMK, were added 2 h before treatment with
NF-a. Figure 3 shows the percentages of cytotoxicity
measured by the release of LDH into the culture super-
natants. The percentages of cytotoxicity were decreased
by addition of Z-VAD-FMK or Z-DEVD-FMK in a dose-
dependent manner in CRFK/FIV cells, but Ac-YVAD-CMK
showed only partial inhibition of cell death in CRFK/FIV
cells. These results indicate that TNF-a-induced cell
eath in CRFK/FIV cells is mediated through the activa-
ion of the caspase cascade.
We also examined the morphological changes in
RFK/FIV cells treated with TNF-a and the caspase in-
hibitors. Most of the CRFK/FIV cells underwent apoptosis
after treatment with TNF-a (5 ng/ml) for 12 h, but the
different caspase inhibitors. CRFK/FIV cells were pretreated with the
(B), and Ac-YVAD-CMK (C) for 2 h and then cultured for 12 h in thethree
D-FMKfter treatment with TNF-a for 12 h, the percentages of cytotoxicity were
are expressed as means 6 SD of triplicate assays.
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449TNF-a-INDUCED DEATH IN FIV-INFECTED CELLSapoptosis observed in CRFK/FIV cells was almost com-
pletely inhibited by the addition of Z-VAD-FMK (10 mM).
reatment with a caspase inhibitor, Z-VAD-FMK,
ncreased the production of FIV
Previously, we reported that RT activity declined in the
ulture supernatant of CRFK/FIV cells that underwent
poptosis after treatment with TNF-a (Ohno et al., 1993).
o examine the effect of caspase inhibitor on virus pro-
uction in CRFK/FIV cells, we examined RT activity in
RFK/FIV cells treated with TNF-a and/or Z-VAD-FMK. As
shown in Fig. 4, RT activity in the culture supernatant of
CRFK/FIV cells that underwent apoptosis induced by
TNF-a treatment was significantly decreased. The de-
crease of RT activity induced by TNF-a treatment was
almost completely restored, by addition of Z-VAD-FMK, to
the level of the culture supernatant of CRFK/FIV cells
before the treatment with TNF-a.
Cleavage of Poly(ADP-ribose) Polymerase (PARP) was
detected in CRFK/FIV cells but not in uninfected
CRFK cells after treatment with TNF-a
PARP is known as a main substrate for caspase 3, a
caspase that functions at the final step of signal trans-
duction of apoptosis (Nagata, 1997). It has been shown
that activation of caspase 3 cleaves 113-kDa PARP into
two fragments of 89 and 24 kDa. To confirm the activation
of caspase 3 during TNF-a-induced cell death in CRFK/
IV cells, cell extracts prepared at different times after
FIG. 4. Effect of TNF-a and Z-VAD-FMK on the production of FIV from
CRFK/FIV cells. RT activity in the culture supernatant of CRFK/FIV cells
treated with TNF-a (10 ng/ml) or Z-VAD-FMK (10 mM) or both is shown.
Results are expressed as means 6 SD of triplicate assays. *P , 0.05.ddition of TNF-a were analyzed by Western blotting
sing anti-PARP polyclonal antibody. As shown in Fig. 5,leavage of 113-kDa PARP into the 89-kDa fragment was
bserved in CRFK/FIV cells from 3 h after the initiation of
he treatment with TNF-a. No cleavage of PARP was
found in uninfected CRFK cells during treatment with
TNF-a for 12 h. The result indicated that caspase 3 was
ctivated when TNF-a induced cell death in CRFK/FIV
cells.
Activation of NF-kB was detected in both CRFK and
RFK/FIV cells treated with TNF-a
Nuclear extracts of CRFK and CRFK/FIV cells before
and after addition of TNF-a (final concentration, 5 ng/ml)
were analyzed by electrophoretic mobility shift assay
(EMSA) (Fig. 6). In the cell extracts of uninfected CRFK
cells, two upper bands became more intense 1 and 3 h
after addition of TNF-a, and these bands were abolished
by competition with unlabeled NF-kB motif oligonucleo-
tide. Moreover, when the nuclear extracts were incu-
bated with anti-p65 antibody prior to the addition of
labeled NF-kB motif oligonucleotide, a supershift band
larger than the NF-kB–DNA complex was generated,
ndicating the presence of p65 in the complex. The re-
ults of EMSA using the NF-kB motif oligonucleotide in
RFK/FIV cells were similar to those in uninfected CRFK
ells. NF-kB was shown to be similarly activated by the
treatment with TNF-a in both CRFK cells and CRFK/FIV
ells, indicating that the NF-kB activation pathway was
not associated with the difference in sensitivity to TNF-a
for the induction of apoptosis between CRFK/FIV cells
and uninfected CRFK cells.
The NF-kB activity in the uninfected CRFK cells and
RFK/FIV cells before and after treatment with TNF-a
was also examined by an experiment using a reporter
plasmid, pkBtkLuc construct, which contains three cop-
ies of NF-kB-binding sites and the firefly luciferase re-
porter gene (Fig. 7). In both the uninfected CRFK cells
and the CRFK/FIV cells, the relative luciferase activity
was increased 1 and 3 h after addition of TNF-a, indicat-
ing that the activity of NF-kB was increased after addition
f TNF-a. Moreover, the activity of NF-kB as shown by
the luciferase activity in CRFK/FIV cells was higher than
that in uninfected CRFK cells before and after treatment
of TNF-a, indicating that FIV infection did not inhibit RNA
or protein synthesis in CRFK cells.
FIG. 5. Cleavage of PARP in uninfected CRFK and CRFK/FIV cells
treated with TNF-a. Cell lysates of CRFK and CRFK/FIV cells at the
imes indicated after addition of TNF-a (5 ng/ml) were subjected to
Western blot analysis using anti-PARP antibody. Bands corresponding
to the authentic PARP (113 kDa) and its cleaved product (89 kDa) are
indicated.
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In this study, we investigated the molecular mecha-
ism of TNF-a-induced apoptosis in CRFK/FIV cells.
TNF-a rarely induces apoptosis even if TNF-a binds to
TNFR unless RNA or protein synthesis is blocked, indi-
cating that there may be some cellular factors synthe-
sized in the cell which suppress the apoptotic signal
generated by TNF-a. Thus, to examine whether TNFR on
he cell surface of uninfected CRFK cells is functional,
he CRFK cells were pretreated with ActD or CHX in
ddition to TNF-a. Low concentrations of TNF-a induced
apoptosis in the uninfected CRFK cells in the presence of
ActD or CHX, suggesting that the TNFR I was functional
on the cell surface of CRFK cells.
TNFR I and TNFR II are known to exist as soluble
forms, in the culture supernatant or serum, which are
generated by proteolytic cleavage of authentic TNFR I
and TNFR II. These soluble forms can block the binding
of TNF-a to TNFRs. Thus, the expression of TNFR I and
FIG. 6. Activation of NF-kB induced by TNF-a in uninfected CRFK and
CRFK/FIV cells. Nuclear extracts were prepared from uninfected CRFK
(A) and CRFK/FIV (B) cells after treatment with TNF-a (5 ng/ml) for 1 or
3 h and then subjected to an electrophoretic mobility shift assay with
radiolabeled NF-kB consensus oligonucleotide in the presence or
bsence of the unlabeled consensus competitor oligonucleotide. For
upershift assay, before incubation with radiolabeled NF-kB oligonu-
cleotide, the nuclear extracts were incubated with anti-p65 NF-kB
antibody. The supershift assay using anti-p65 NF-kB antibody was
arried out for the samples treated with TNF-a for 3 h.TNFR II mRNAs does not directly correlate with the level
of expression of the membrane-bound molecules. Al- wthough we detected the expression of TNFR I and TNFR
II mRNAs in both CRFK and CRFK/FIV cells in this study,
we could not detect the proteins of TNFR I and TNFR II
because specific antibodies directed to these molecules
were not available. As mentioned above, however, cell
death was observed in uninfected CRFK cells when ActD
or CHX was added to the culture, suggesting that TNFRs
were constitutively expressed on the cell surface of un-
infected CRFK cells, as well as CRFK/FIV cells, in which
apoptosis was easily induced by TNF-a even in the
bsence of ActD or CHX.
It has been shown that binding of TNF-a to TNFR
stimulates not only the caspase cascade but also NF-kB
nuclear translocation. We examined the activation of the
caspase cascade and NF-kB translocation to identify the
echanism of difference in the sensitivity to TNF-a for
induction of apoptosis between CRFK and CRFK/FIV
cells. Fourteen molecules belonging to the caspase fam-
ily have been found in mammalian cells and each of
them participates in the caspase cascade to induce
apoptotic cell death (Kumar, 1999). Based on their sub-
strate specificity, the caspase family is divided into three
groups. Group I, group II, and group III are composed of
caspases 2, 3, 6, 7, 8, 9, and 10, caspases 1, 4, 5, and 11,
and caspases 12, 13, and 14, respectively. The three
caspase inhibitors used in this study, Z-VAD-FMK, Z-
DEVD-FMK, and Ac-YVAD-CMK, inhibit caspases 1, 3, 4,
and 7, caspases 3, 6, 7, 8, and 10, and caspases 1 and 4,
respectively. Z-VAD-FMK and Z-DEVD-FMK efficiently
blocked TNF-a-induced cell death in CRFK/FIV cells in
his study, whereas Ac-YVAD-CMK showed only a partial
ffect. The results suggested that ICE protease and
aspase 3 were involved in the TNF-a-induced cell death
in CRFK/FIV cells. The partial effect of Ac-YVAD-CMK on
the inhibition of apoptosis was possibly due to inefficient
cellular uptake of this agent or the incomplete inhibition
of caspases 1 and 4 by Ac-YVAD-CMK. Several caspase
inhibitors have been shown to block apoptosis in various
viral infections. Z-VAD-FMK blocked transmissible gas-
troenteritis coronavirus-induced apoptosis, which was
mediated by the oxidative stress pathway, but not by
inhibition of NF-kB (Sirinarumitr et al., 1998). In bovine
herpesvirus 1 infection, activation of caspase and p53
resulted in apoptosis (Devireddy and Jones, 1999). Par-
vovirus H-1 induced apoptosis in U937 cells, accompa-
nied with activation of caspase and downregulation of
c-Myc protein (Ray et al., 1998). It was also reported that
hepatitis C virus core protein was bound to the cytoplas-
mic domain of TNFR I and enhanced TNF-a-induced
apoptosis through blocking of NF-kB activation (Zhu et
al., 1998). In HIV infection, Z-VAD-FMK was shown to
inhibit Fas-induced apoptosis in peripheral blood CD41
and CD81 T cells of asymptomatic HIV carriers (Katsikis
t al., 1997) and in a human T cell line infected with HIV.We identified the cleavage of PARP in CRFK/FIV cells
hich underwent apoptosis induced by TNF-a treatment.
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451TNF-a-INDUCED DEATH IN FIV-INFECTED CELLSPARP, which is involved in DNA repair, is one of the
substrates of caspase 3 during apoptosis. In this study,
TNF-a was shown to trigger the cleavage of PARP and a
road caspase inhibitor could inhibit apoptosis induced
y TNF-a, indicating that caspase 3 was activated when
RFK/FIV cells underwent apoptosis after treatment with
NF-a.
We previously reported that TNF-a treatment reduced
virus production from CRFK/FIV cells (Ohno et al., 1993).
The decrease of the virus production in the cells that
underwent apoptosis induced by TNF-a treatment was
shown to be restored to the level of the untreated cells in
this study. It was shown that Z-VAD-FMK itself did not
enhance the virus production in CRFK/FIV cells because
RT activity in the CRFK/FIV cells did not change after
treatment with Z-VAD-FMK alone. In HIV-1 infection, T-
cell leukemia cells and peripheral blood mononuclear
cells exposed to HIV-1 also showed enhanced viral pro-
duction in the presence of Z-VAD-FMK (Chinnaiyan et al.,
1997). It is conceivable that the increase of viable cells by
inhibition of apoptosis leads to the enhancement of virus
production. Because inhibition of cell death was shown
to apparently enhance the virus production, inhibition of
apoptosis with caspase inhibitors in vivo may not be
appropriate for therapy in cats infected with FIV and
humans infected with HIV-1.
FIG. 7. NF-kB luciferase reporter assay showing the activation of NF
RFK (A) and CRFK/FIV (B) cells transfected with the pkBtkLuc const
reporter gene, were treated with TNF-a (5 ng/ml) for 1 or 3 h and then
on the NF-kB activity. Results are expressed as means 6 SD of triplicMoreover, we examined NF-kB activation during TNF-
a-induced apoptosis and found that activation of NF-kB
i
ioccurred after treatment with TNF-a in both uninfected
nd FIV-infected CRFK cells. In both the EMSA and the
F-kB–luciferase reporter assay, the degree of NF-kB
activation after treatment with TNF-a was apparently
imilar between the uninfected and the FIV-infected
RFK cells. From these results, it is conceivable that the
ifferent susceptibility to TNF-a in the induction of apo-
tosis between the uninfected and the FIV-infected CRFK
ells cannot be explained by the difference in the acti-
ation of the NF-kB pathway. Prior to treatment with
NF-a, the band corresponding to the NF-kB–DNA com-
plex in CRFK/FIV cells was less intense than that in
uninfected CRFK cells in EMSA; however, luciferase ac-
tivity derived from the pkBtkLuc reporter construct in
CRFK/FIV cells was higher than that in uninfected CRFK
cells in the NF-kB luciferase reporter assay. There
eemed to be a contradiction between the results in
hese two different assays for the measurement of NF-kB
activity. But, the results in the NF-kB luciferase reporter
assay were conceivably more reliable because this as-
say reflects not only DNA binding of NF-kB but also the
succeeding RNA and protein synthesis. The data ob-
tained from the NF-kB luciferase reporter assay in this
tudy also support the notion that FIV infection does not
nhibit RNA or protein synthesis; therefore, the apoptosis
uced by TNF-a in the uninfected CRFK and CRFK/FIV cells. Uninfected
hich contains three copies of NF-kB-binding sites and the luciferase
ed to the assay for the reporter luciferase activity, which is dependent
ays.-kB ind
ruct, wnduced in CRFK/FIV cells by TNF-a treatment can be
nterpreted as a phenomenon different from the apopto-
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452 MIZUNO ET AL.sis induced by chemical inhibitors such as ActD and
CHX.
Binding of NF-kB to the long terminal repeat (LTR) of
HIV-1 was shown to lead to the enhancement of HIV-1
replication. In this study, RT activity was reduced in
CRFK/FIV cells after treatment with TNF-a. This result
seems to conflict with the phenomenon in HIV-1-infected
cells treated with TNF-a. Unlike HIV-1, there is no NF-kB
binding site in the FIV LTR; therefore, virus replication
was suppressed possibly due to the decrease of viable
cells because of TNF-a-induced apoptosis.
Recently, membrane-bound TNF-a-mediated apopto-
is was reported in HIV infection. Membrane-bound
NF-a expressed on macrophages was shown to induce
apoptosis in CD81 T cells expressing TNFR II (Herbein et
al., 1998), but the mechanism involved in TNFR II-induced
cell death was not clear. Lazdins et al. reported that
membrane-bound TNF induced cooperative signaling of
TNFR I and TNFR II, which resulted in the induction of
cell death rather than virus production in the cells la-
tently infected with HIV (Lazdins et al., 1997). In this
study, we detected the expression of TNFR II mRNA in
both CRFK and CRFK/FIV cells but the involvement of
TNFR II in apoptosis was not analyzed. The mechanism
of apoptosis mediated by the membrane-bound TNF will
be investigated in further studies.
In this study, we showed that TNF-a-induced apopto-
sis in CRFK/FIV cells was mediated by activation of the
caspase cascade but not by the increased expression of
TNFRs or inhibition of NF-kB. Because the activation of
caspase directly associated with the induction of apo-
ptosis was clearly different between the uninfected CRFK
cells and the CRFK/FIV cells, further investigation of the
mechanism responsible for the activation of caspase by
FIV infection would clarify the molecular basis for virus-
induced apoptosis.
MATERIALS AND METHODS
Cells and cell cultures
A feline fibroblastic cell line derived from feline kidney
(CRFK) and CRFK chronically infected with the Petaluma
strain of FIV (CRFK/FIV) were used in this study. These
cell lines were maintained in DMEM containing penicil-
lin/streptomycin and 10% heat-inactivated fetal calf se-
rum (FCS).
Caspase inhibitors
Three different classes of caspase inhibitors, Z-VAD-
FMK (broad-spectrum inhibitor of ICE-like proteases),
Z-DEVD-FMK (inhibitor of caspase 3-like enzymes), and
Ac-YVAD-CMK (inhibitor of ICE) (Calbiochem, La Jolla,
CA), were used in this study. All of the caspase inhibitors
were dissolved in dimethyl sulfoxide and then diluted
(25–200 mM) in the culture media.
Geverse transcriptase assay
Culture supernatants (1 ml per sample) were first cen-
rifuged at 750 g for 10 min to remove cell debris and
then recentrifuged at 20,000 g for 2 h. The resulting
pellets were suspended in 10 ml of TNE buffer (0.1 M
NaCl, 0.01 M Tris–HCl, pH 7.6, and 0.001 M EDTA) sup-
plemented with 1% Nonidet P-40 and then mixed with 90
ml of RT assay buffer containing 90 mg of poly(A) (Sigma
hemical, St. Louis, MO) per milliliter, 20 mg of oligo(dT)
(Amersham Pharmacia Biotech, Buckinghamshire, UK)
per milliliter, 10 mM MgCl2, and 10 mCi of [
3H]dTTP
(Moravek Biochemicals, CA). After incubation at 37°C for
1 h, the mixtures were spotted onto DE81 filter papers
(Whatman International, Maidstone, England), air-dried,
and washed three times with 5% Na2HPO4 and twice
ith 99% ethanol. The filter papers were then dried, and
he incorporated radioactivity on the filter paper was
easured with a scintillation counter. Group mean data
ere statistically compared by t tests. Differences be-
ween the groups were considered to be significant at
, 0.05.
everse transcription-PCR analysis
Total RNA was extracted from the cell lines using the
cid guanidium–phenol–chloroform method with RNAzol
Biotecx, Houston, TX). After removal of DNA contamina-
ion using DNase I (Life Technologies, Rockville, MD), 0.5
mg of total RNA was reverse-transcribed using the RNA
PCR Kit (PE Biosystems, Foster City, CA) in the presence
of oligo(dT). PCR amplification of TNFR I and TNFR II
genes was performed as per the manufacturer’s instruc-
tion. For RT-PCR analysis, the reaction for the house-
keeping b-actin gene was used as an internal control.
he PCR consisted of 15, 20, 25, or 30 cycles of dena-
uration at 95°C for 1 min and annealing and polymer-
zation at 60°C for 1 min followed by final extension at
2°C for 7 min. The amplified products were electro-
horetically separated through a 3% agarose gel and
isualized by staining with ethidium bromide. Each
rimer pair was designed to amplify partial fragments in
he coding region of feline TNFR I, TNFR II, and b-actin
enes. The sequences of the PCR primers were as
ollows: sense primer for feline TNFR I, 59-CGA AGT GCC
CA AAG GGA CCT AC-39 (nt 388–411 in the feline TNFR
gene, GenBank/EMBL/DDBJ Accession No. AB051103),
everse primer for feline TNFR I, 59-TGG TTC TTC CTG
AG CCA CAC AC-39 (nt 601–579); sense primer for
eline TNFR II, 59-CTC AGG CAG CAC CGC AGA CGG-39
nt 1–21 in the feline TNFRII gene, GenBank/EMBL/DDBJ
ccession No. U51429), reverse primer for feline TNFR II,
9-GCC GGA GGA GCT GGC ATC CAC G-39 (nt 247–226);
ense primer for b-actin, 59-GGG GTC ACC CAC ACT
TG CCC ATC-39 (nt 284–307 in the feline b-actin gene,
GenBank/EMBL/DDBJ Accession No. AB051104), reverse
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TG-39 (nt 672–649).
ytotoxicity assay
Cytotoxicity induced by TNF-a was examined using
he Cytotoxicity Detection Kit (LDH) (Roche Molecular
iochemicals, Mannheim, Germany). Prior to the assay,
he cells (4 3 105 cells/well) were cultured for 12 h. Then
he culture supernatants were removed, and the cells
ere incubated in fresh serum-free medium (OPTI-MEM)
Life Technologies) containing 2% FCS with or without
aspase inhibitors, 0.1 mg of ActD per milliliter (Sigma
Chemical), and 0.1 mg of CHX per milliliter (MBL, Nagoya,
apan). Two hours later, the medium containing TNF-a
was added to a final concentration of 0.1–10 ng/ml. The
supernatants were harvested after treatment with TNF-a
for 12 h and tested for cytotoxicity according to the
manufacturer’s instructions. LDH activity estimated by
the absorbance at 490 nm was measured with a spec-
trophotometer. To determine the percentage cytotoxicity,
from the LDH activity of the sample, LDH activity in the
background control was subtracted. The percentage of
cytotoxicity was expressed as (value of sample 2 mini-
um control value) 3 100/(maximum control value 2
inimum control value). Maximum control value corre-
ponds to LDH activity obtained after complete lysing of
ntreated control cultures with 0.2% Triton X-100. Mini-
um control value corresponds to the LDH activity re-
eased from the untreated normal cells.
estern blot analysis
For Western blot analysis, cells were washed with PBS
nd then lysed in 100 ml of ice-cold RIPA buffer (50 mM
Tris–HCl, pH 7.6, 150 mM NaCl, 1% Nonidet P-40, 0.5%
sodium deoxycholate, 0.1% SDS) (Boehringer Mann-
heim). The protein concentration was determined using
the Bradford reagent (Bio-Rad, Hercules, CA). The pro-
tein preparations from the cell extracts were separated
by SDS–PAGE and subjected to Western blot analysis
using rabbit anti-PARP polyclonal antibody (Pharmingen,
San Diego, CA). Horseradish peroxidase-conjugated
goat anti-rabbit IgG (Bio-Rad) was used as a secondary
antibody and the reaction was visualized using an ECL
chemiluminescence system (Amersham Pharmacia Bio-
tech).
Electrophoretic mobility shift assay
Activated NF-kB was assayed using a gel shift assay
it (Promega, Madison, WI). Nuclear extracts were pre-
ared according to the method by Schreiber et al. (1989).
Briefly, 2 3 106 cells were washed with cold PBS and
suspended in 0.4 ml of hypotonic lysis buffer containing
a protease inhibitors cocktail (Sigma Chemical). The
cells were then lysed by the addition of 25 ml of 10%
onidet P-40. The homogenates were centrifuged, andhe resultant pellet was resuspended in 100 ml of ice-
cold nuclear extraction buffer. After intermittent mixing
for 30 min, the tubes were centrifuged at 20,000 g at 4°C
for 5 min, and the supernatant (nuclear extract) was used
for assay immediately or stored at 280°C for later use.
The protein content was measured by the Bradford
method. EMSA was performed according to the manu-
facturer’s instructions. Briefly, 10 mg of the nuclear ex-
ract was incubated with 17.5 pmol of 32P-end-labeled
1-mer double-stranded NF-kB motif oligonucleotide
Promega) at 37°C for 15 min. The incubation mixture
ncluded 2–3 mg of poly(dI–dC) in a binding buffer. The
DNA–protein complex formed was separated from free
oligonucleotide through native 6.6% polyacrylamide gel
electrophoresis, and then the gel was dried. The speci-
ficity of binding was also examined by competition with
the unlabeled oligonucleotide. For supershift assays, the
nuclear extracts were incubated with 2 mg of anti-p65
F-kB antibody (Oncogene Research Product, Cam-
bridge, MA) for 1 h and then subjected to EMSA.
NF-kB promoter assay
Cells (1.0 3 106) were cultured for 12 h and then
ransfected with the NF-kB-dependent luciferase re-
porter plasmid, pkBtkLuc (Kashiwada et al., 1998), using
the Effectene reagent (Qiagen, Chatsworth, CA) accord-
ing to the manufacturer’s instruction. The pkBtkLuc con-
struct contains the firefly luciferase reporter gene to-
gether with three copies of the NF-kB-binding site de-
ived from immunogobulin k light chain enhancer and
hymidine kinase promoter. The pRL-TK construct (Pro-
ega), containing the Renilla luciferase gene, was co-
transfected with the pkBtkLuc construct to normalize the
transfection efficiency by dual-promoter assay. Twenty-
four hours after transfection, the cells were further cul-
tured for 1 to 3 h in the presence of 5 ng of TNF-a per
illiliter. After treatment with TNF-a, the cells were lysed
and the luciferase activity was measured with the Dual
Luciferase Reporter Assay System (Promega). Cell de-
bris was removed by centrifugation at 20,000 g for 30 s,
and the luciferase activity in 20 ml of the supernatant was
easured in triplicate with an Autolumat LB953 lumi-
ometer (EG&G, Bethold, Germany). Values of firefly lu-
iferase activity derived from pkBtkLuc construct were
tandardized by values of Renilla luciferase activity de-
ived from the pRL-TK construct. The values of the stan-
ardized luciferase activity were divided by the values of
he luciferase activity derived from the pGL3Basic con-
truct (Promega), which does not contain the NF-kB-
binding site, and then the fold increases were calculated
to show the activation of NF-kB in the cells.
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